| Recruiting | Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer NCT07482566 | Nurettin Şahin | N/A |
| Recruiting | Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA) NCT07161479 | Samsung Medical Center | N/A |
| Not Yet Recruiting | The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal NCT07260461 | First Affiliated Hospital of Wenzhou Medical University | N/A |
| Recruiting | A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791 | Eli Lilly and Company | Phase 1 |
| Recruiting | Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies NCT04949737 | University Hospital Center of Martinique | — |
| Not Yet Recruiting | Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer NCT07007182 | Jinbo Yue | Phase 2 |
| Not Yet Recruiting | Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gast NCT07183358 | The Affiliated Hospital of Qingdao University | N/A |
| Recruiting | Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumo NCT06885697 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQ NCT07504913 | Parc de Salut Mar | — |
| Active Not Recruiting | Carina™ Surgical Platform for Minimal Radical Gastrectomy NCT07113340 | The Affiliated Hospital of Qingdao University | N/A |
| Recruiting | Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer NCT06630130 | Jeeyun Lee | Phase 2 |
| Recruiting | Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Ga NCT06576921 | Xijing Hospital | Phase 2 |
| Recruiting | Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Se NCT07035587 | Yonsei University | — |
| Recruiting | To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer NCT06504732 | SUNHO（China）BioPharmaceutical CO., Ltd. | Phase 2 / Phase 3 |
| Not Yet Recruiting | A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Can NCT06564298 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Recruiting | Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Ther NCT07309185 | Shandong Tumor Hospital | Phase 2 |
| Recruiting | Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early NCT05892289 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | N/A |
| Completed | Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients NCT06548464 | Chang-Ming Huang, Prof. | — |
| Recruiting | A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors NCT06157892 | Seagen, a wholly owned subsidiary of Pfizer | Phase 2 |
| Completed | Prediction Model for Advanced Gastric Cancer in Elderly NCT06467591 | Chang-Ming Huang, Prof. | — |
| Completed | Model for Prognosis of Elderly Gastric Cancer Patients NCT06393153 | Chang-Ming Huang, Prof. | — |
| Enrolling By Invitation | Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer NCT06776835 | Affiliated Hospital of Nantong University | — |
| Not Yet Recruiting | The Role of Artificial Intelligence in Endoscopic Diagnosis of Esophagogastric Junctional Adenocarcinoma：A Sin NCT05819099 | Qilu Hospital of Shandong University | — |
| Recruiting | A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840 | Seagen, a wholly owned subsidiary of Pfizer | Phase 1 |
| Recruiting | HTL0039732 in Participants With Advanced Solid Tumours NCT05944237 | Cancer Research UK | Phase 1 / Phase 2 |
| Not Yet Recruiting | Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-e NCT05890339 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | N/A |
| Recruiting | Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer NCT06451211 | Sun Yat-sen University | Phase 2 |
| Unknown | The Effects of Sufentanil vs. Remifentanil in Total Intravenous Anesthesia With Remimazolam on Postoperative P NCT05785234 | Yonsei University | N/A |
| Unknown | Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients. NCT06260150 | Feng Tian | N/A |
| Unknown | Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer NCT05795296 | RenJi Hospital | Phase 2 |
| Unknown | Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined NCT06047158 | The Affiliated Hospital of Qingdao University | — |
| Unknown | Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenoca NCT05625737 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Active Not Recruiting | Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer NCT05352802 | The Affiliated Hospital of Qingdao University | N/A |
| Active Not Recruiting | A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced NCT05334719 | Bristol-Myers Squibb | — |
| Terminated | A Study of SGN-ALPV in Advanced Solid Tumors NCT05229900 | Seagen Inc. | Phase 1 |
| Unknown | Gut Microbiota and Metabonomics NCT05205187 | First Hospital of China Medical University | — |
| Completed | Specialization in Gastric Cancer Surgery NCT05280665 | Karadeniz Technical University | — |
| Completed | Development and Testing of a Social Cognitive Theory-based Dietary Behavioral Intervention in Gastric Cancer S NCT04985084 | The Hong Kong Polytechnic University | N/A |
| Unknown | Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer NCT05208372 | First Hospital of China Medical University | — |
| Unknown | Total Versus Partial Omentectomy in the Treatment of Gastric Cancer NCT05238584 | University of Debrecen | N/A |
| Unknown | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients NCT05068180 | RenJi Hospital | Phase 4 |
| Not Yet Recruiting | HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction NCT05095467 | Xuefei.Wang | Phase 2 |
| Terminated | Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer NCT05161572 | Fudan University | Phase 2 |
| Completed | MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) NCT05007106 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer NCT05033392 | Wan He | Phase 2 |
| Terminated | A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Ca NCT04945733 | Janssen Pharmaceutical K.K. | Phase 2 |
| Terminated | A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 NCT04933227 | Hoffmann-La Roche | Phase 2 |
| Unknown | Multi-center and Multi-modal Deep Learning Study of Gastric Cancer NCT05001321 | First Hospital of China Medical University | — |
| Unknown | Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis NCT04943653 | Seoul St. Mary's Hospital | Phase 1 / Phase 2 |
| Recruiting | PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI NCT05172310 | Karolinska University Hospital | Phase 1 |
| Recruiting | Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer NCT04809025 | Fudan University | — |
| Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 NCT04949282 | Sociedad Española de Medicina Nuclear e Imagen Molecular | — |
| Active Not Recruiting | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors NCT04660929 | Carisma Therapeutics Inc | Phase 1 |
| Recruiting | Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer NCT04710758 | Shanghai Zhongshan Hospital | N/A |
| Terminated | A Study of SGN-STNV in Advanced Solid Tumors NCT04665921 | Seagen Inc. | Phase 1 |
| Unknown | Comparison of the Efficiency Between Intraoperative and Postoperative Hyperthermic Intraperitoneal Chemotherap NCT04522011 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Unknown | Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Ch NCT04222114 | LintonPharm Co.,Ltd. | Phase 3 |
| Unknown | Methylation Analysis of Circulating Tumor DNA in Gastric Cancer NCT04511559 | Shanghai Zhongshan Hospital | — |
| Unknown | L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System NCT04526483 | Shanghai Minimally Invasive Surgery Center | N/A |
| Active Not Recruiting | Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gas NCT05602935 | The Second Affiliated Hospital of Fujian Medical University | Phase 2 |
| Unknown | A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer NCT04351867 | LiNing | Phase 3 |
| Completed | The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer NCT04694183 | Quan Wang | Phase 2 |
| Completed | Quantitative Fluorescent Guided Robotic Surgery for Cancer of the Gastroesophageal Junction NCT04107623 | Rigshospitalet, Denmark | N/A |
| Recruiting | A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632 | Seagen, a wholly owned subsidiary of Pfizer | Phase 1 |
| Unknown | Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study NCT03917173 | Mario Negri Institute for Pharmacological Research | N/A |
| Completed | Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy NCT04360577 | Guangzhou University of Traditional Chinese Medicine | N/A |
| Active Not Recruiting | Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gast NCT03979131 | Vall d'Hebron Institute of Oncology | Phase 2 |
| Unknown | Trials Comparing of HD Versus 4K Laparoscopy for Gastric Cancer NCT04010006 | Fujian Medical University | N/A |
| Unknown | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer NCT03889626 | Fudan University | Phase 3 |
| Unknown | Prediction of the Efficacy of ctDNA in Immunotherapy for Advanced Gastric Cancer NCT04053725 | Sun Yat-sen University | — |
| Unknown | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma NCT04393584 | Blokhin's Russian Cancer Research Center | Phase 2 / Phase 3 |
| Completed | Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study NCT03753399 | Guangzhou University of Traditional Chinese Medicine | N/A |
| Completed | Effectiveness of Managing Suspected Metastasis and Progress Using Plasma D-dimer Testing in Gastric Cancer Pat NCT04953585 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I NCT02845479 | The Canadian College of Naturopathic Medicine | Phase 3 |
| Completed | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroes NCT03675737 | Merck Sharp & Dohme LLC | Phase 3 |
| Withdrawn | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroes NCT04859582 | Merck Sharp & Dohme LLC | Phase 3 |
| Unknown | Application of 3D Printing Technique in Radical Gastrectomy With Leonardo da Vinci Robot NCT03599895 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Withdrawn | Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer NCT02594943 | Region Skane | N/A |
| Unknown | The Effect of Postoperative Referred Pain in the Left Shoulder on Short-term Outcomes for Laparoscopic Gastrec NCT03482609 | Fujian Medical University | — |
| Unknown | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With M NCT03475615 | Fudan University | Phase 3 |
| Completed | Robotic Total Gastrectomy for Locally Advanced Proximal Gastric Cancer NCT03524287 | Fujian Medical University | N/A |
| Unknown | Comparison of Open Laparoscopic and Robotic Surgery in Gastric Cancer Resection. NCT03447106 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Completed | Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Re NCT03425773 | Cellid Co., Ltd. | Phase 1 |
| Withdrawn | Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Les NCT02919553 | Loma Linda University | N/A |
| Completed | Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection NCT03050879 | Fujian Medical University | Phase 2 |
| Unknown | Learning Curve for Robot-Assisted Gastrectomy in Gastric Cancer NCT03940417 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | Impact of the Type of Reconstruction Methods on Diabetes Following Laparoscopic Distal Gastrectomy in Patients NCT04539769 | Kyungpook National University Chilgok Hospital | Phase 2 |
| Unknown | Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) NCT03488446 | Nanfang Hospital, Southern Medical University | — |
| Unknown | Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer. NCT03423056 | Instituto Nacional de Cancerologia, Columbia | N/A |
| Completed | Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Met NCT03170180 | Samsung Medical Center | Phase 2 |
| Unknown | Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis NCT03061162 | Yang Yang | N/A |
| Completed | Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression NCT03052478 | Samsung Medical Center | Phase 2 |
| Terminated | Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy NCT03061708 | Samsung Medical Center | Phase 2 |
| Completed | Prospective Evaluation and Molecular Profiling in People With Gastric Tumors NCT03027427 | National Cancer Institute (NCI) | — |
| Unknown | Gastropanel for Gastric Atrophy and Cancer Risk Assessment NCT02114411 | Biohit Healthcare Ltd | — |
| Completed | Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition t NCT03030404 | National Cancer Institute (NCI) | — |
| Unknown | The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites NCT02779608 | Fudan University | Phase 2 |
| Unknown | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer NCT02949258 | Jinling Hospital, China | Phase 2 |
| Unknown | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy NCT02934464 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 3 |
| Unknown | Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Gastrectomy NCT03016026 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Unknown | Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Ga NCT03006263 | Fujian Medical University | N/A |
| Terminated | Early Detection of Esophageal Cancer NCT00341523 | National Cancer Institute (NCI) | — |
| Completed | The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant NCT02902575 | Fujian Medical University | N/A |
| Unknown | The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparosc NCT02930278 | Fujian Medical University | — |
| Unknown | Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer NCT02845986 | Fujian Medical University | Phase 2 |
| Unknown | The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic NCT02930291 | Fujian Medical University | — |
| Unknown | ctDNA for Prediction of Relapse in Gastric Cancer NCT02887612 | Sun Yat-sen University | — |
| Unknown | Randomized Controlled Trials on Laparoscopic No. 14v LNS Dissection NCT02789891 | Fujian Medical University | N/A |
| Completed | Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors NCT02658214 | AstraZeneca | Phase 1 |
| Completed | Association Between Mitochondrial DNA Content and Risk of Gastric Cancer NCT02944539 | Air Force Military Medical University, China | — |
| Terminated | A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression NCT02512237 | Zhejiang Medicine Co., Ltd. | Phase 1 |
| Completed | The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD NCT02730533 | Xijing Hospital of Digestive Diseases | N/A |
| Unknown | Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy NCT02837874 | Keimyung University Dongsan Medical Center | N/A |
| Completed | Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial NCT02298010 | Seoul National University Hospital | — |
| Unknown | Serological Screening of Gastric Cancer in Wuxi Region NCT02663427 | Wuxi People's Hospital | N/A |
| Completed | Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Po NCT02650661 | Seoul National University Hospital | N/A |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer NCT02725125 | Sinobioway Cell Therapy Co., Ltd. | N/A |
| Completed | Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome NCT02649348 | Qingdao University | N/A |
| Completed | Laparotomy, Laparoscopy, da Vinci System NCT07034495 | National Chung Hsing University | — |
| Unknown | Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers NCT02777801 | Sun Yat-sen University | Phase 2 |
| Unknown | Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma NCT03400592 | Peking University | Phase 2 |
| Active Not Recruiting | The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer NCT02485015 | The First People's Hospital of Changzhou | Phase 2 |
| Completed | Postoperative Analgesic Effect of Nefopam NCT02561494 | Seoul National University Bundang Hospital | N/A |
| Unknown | The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric Cancer NCT02431078 | wei bo | — |
| Unknown | Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer NCT02289547 | The Catholic University of Korea | Phase 3 |
| Unknown | Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cance NCT02577263 | Pontificia Universidad Catolica de Chile | — |
| Completed | Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma NCT02406170 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1 / Phase 2 |
| Unknown | Irinotecan as 3rd Line Therapy in Gastric Cancer NCT02662959 | Fudan University | Phase 2 |
| Unknown | Lifestyle Intervention for Prevention of Gastric Neoplasm NCT02679495 | Shandong University | N/A |
| Completed | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery NCT02381249 | St. James's Hospital, Ireland | N/A |
| Completed | Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer NCT02385630 | St. James's Hospital, Ireland | N/A |
| Completed | A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer NCT02359058 | Eli Lilly and Company | Phase 1 |
| Unknown | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients NCT02338518 | Jinling Hospital, China | Phase 3 |
| Unknown | Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastr NCT02289183 | Fujian Medical University | N/A |
| Unknown | Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors NCT02313688 | West China Hospital | N/A |
| Completed | Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms NCT02430636 | Fuda Cancer Hospital, Guangzhou | N/A |
| Unknown | Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastri NCT02333721 | Fujian Medical University | N/A |
| Completed | Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Canc NCT02327481 | Fujian Medical University | N/A |
| Completed | An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy NCT02310230 | Donald Mathews | N/A |
| Completed | The Screening Protocol for The VIKTORY Trial NCT02299648 | Samsung Medical Center | N/A |
| Unknown | Single-center Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer NCT02219854 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma NCT02177552 | Rigshospitalet, Denmark | Phase 2 |
| Completed | No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy NCT02200315 | Korean South West East Gastric Surgery Group | Phase 2 |
| Unknown | Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric NCT02136836 | Yonsei University | — |
| Completed | A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects NCT02096666 | Amgen | Phase 1 / Phase 2 |
| Unknown | Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for G NCT02085031 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Completed | Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer NCT02305043 | University of Leipzig | — |
| Terminated | Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors NCT02016534 | Amgen | Phase 2 |
| Completed | A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcin NCT02301481 | Chinese Academy of Medical Sciences | Phase 2 |
| Completed | Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer NCT02385617 | St. James's Hospital, Ireland | N/A |
| Unknown | A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer NCT02296658 | Chinese Academy of Medical Sciences | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer NCT01928290 | Washington University School of Medicine | Phase 2 |
| Completed | Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer NCT02004769 | Sun Yat-sen University | Phase 2 |
| Recruiting | Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma NCT01950572 | National Cancer Institute (NCI) | — |
| Terminated | A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in NCT01967875 | China Medical University, China | Phase 2 |
| Unknown | Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy f NCT03061058 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 3 |
| Completed | Botulinum Toxin for Stomach Cancer Treatment NCT01822210 | St. Olavs Hospital | Phase 2 |
| Withdrawn | Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma NCT01821196 | St. Olavs Hospital | N/A |
| Unknown | Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) NCT01609309 | Nanfang Hospital, Southern Medical University | Phase 3 |
| Completed | Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. NCT01649271 | Boehringer Ingelheim | Phase 1 |
| Completed | Compliance to ERAS After Gastric Surgery NCT01653496 | Chonnam National University Hospital | Phase 2 |
| Completed | Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endos NCT01653171 | Pontificia Universidad Catolica de Chile | Phase 4 |
| Completed | A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma NCT01576380 | Novartis Pharmaceuticals | Phase 2 |
| Unknown | Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers NCT01911832 | West China Hospital | Phase 3 |
| Completed | Omentectomy in Radical Gastrectomy for Gastric Cancer Trial NCT02050659 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose NCT01614522 | ASLAN Pharmaceuticals | Phase 2 |
| Completed | Acetic Acid Chromoendoscopy to Judge Gastric Intestinal Metaplasia NCT01499576 | Konyang University Hospital | N/A |
| Completed | The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Pa NCT01421680 | Seoul National University Hospital | N/A |
| Completed | Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy NCT01384253 | Orano Med LLC | Phase 1 |
| Completed | The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer NCT01531452 | Chinese Academy of Medical Sciences | Phase 2 |
| Completed | S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemothe NCT01364376 | Zhejiang University | N/A |
| Completed | Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer NCT01943253 | Shanghai Zhongshan Hospital | N/A |
| Terminated | Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With L NCT01830270 | Centre Hospitalier Universitaire de Besancon | Phase 2 |
| Terminated | Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric NCT01476553 | Universitätsmedizin Mannheim | N/A |
| Completed | ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction NCT01234324 | AIO-Studien-gGmbH | Phase 2 |
| Active Not Recruiting | Helicobacter Pylori Eradication to Prevent Gastric Cancer NCT01133951 | Jie-Jun Wang | N/A |
| Completed | Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer NCT01617876 | Peking Union Medical College Hospital | — |
| Suspended | Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT) NCT02686424 | Seoul National University Hospital | — |
| Completed | Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer NCT04439812 | Hospital Universitario Ramon y Cajal | — |
| Unknown | Gastric Cancer Liver Metastasis Cohort of China NCT04574245 | Chinese PLA General Hospital | — |
| Completed | a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Les NCT01508520 | Xiaobo Li | — |
| Completed | A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or NCT00909402 | Bristol-Myers Squibb | Phase 1 |
| Unknown | Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnife NCT01185483 | Odense University Hospital | — |
| Completed | Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer NCT00983801 | R-Pharm | Phase 2 |
| Completed | Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma NCT02370849 | Chinese Academy of Medical Sciences | Phase 2 |
| Completed | Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer NCT00842244 | Pfizer | Phase 1 |
| Completed | Taxotere New Indication - Gastric Cancer Treatment Registration Trial NCT00811447 | Sanofi | Phase 3 |
| Completed | Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy NCT00851305 | Shandong University | N/A |
| Completed | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer NCT00555672 | Pfizer | Phase 1 |
| Completed | Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Adv NCT00555620 | Pfizer | Phase 1 |
| Completed | Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery NCT04002128 | Osijek University Hospital | N/A |
| Unknown | Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced NCT00591045 | Peking University | Phase 2 |
| Completed | Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer NCT00553696 | Pfizer | Phase 1 |
| Completed | Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma NCT00813072 | PharmaEngine | Phase 2 |
| Terminated | Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery NCT00560846 | Dan Azagury | N/A |
| Completed | Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer NCT00525005 | Hallym University Medical Center | Phase 2 |
| Completed | Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer NCT00511446 | Martin-Luther-Universität Halle-Wittenberg | Phase 2 |
| Completed | Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors NCT00515216 | Vanderbilt University | Phase 2 |
| Completed | A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer NCT00512681 | National Cancer Center, Korea | Phase 2 |
| Unknown | Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma NCT00515190 | National Cancer Center, Korea | Phase 2 |
| Unknown | S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastri NCT00580359 | National Cancer Center, Korea | Phase 2 |
| Withdrawn | huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas NCT00620607 | ImmunoGen, Inc. | Phase 2 |
| Unknown | Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer NCT00420394 | Soroka University Medical Center | Phase 2 |
| Unknown | Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis NCT00454519 | Wuhan University | Phase 2 |
| Unknown | Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas NCT00419627 | Hillel Yaffe Medical Center | — |
| Completed | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma NCT00447330 | Duke University | Phase 2 |
| Completed | Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable NCT00390416 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Docetaxel and Oxaliplatin in Gastric Cancer NCT00382720 | Sanofi | Phase 2 |
| Completed | Docetaxel and Epirubicin in Advanced Gastric Cancer NCT00375999 | Yonsei University | Phase 2 |
| Unknown | Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric NCT00669370 | University of Turku | Phase 2 |
| Unknown | Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer NCT00384878 | Far Eastern Memorial Hospital | Phase 2 |
| Completed | Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer NCT00411229 | Sanofi | Phase 3 |
| Completed | Docetaxel in Locally Advanced Gastric Adenocarcinoma NCT00343239 | Sanofi | Phase 2 |
| Unknown | Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer NCT00587145 | National Cancer Center, Korea | Phase 2 |
| Completed | OLGA and OLGIM Stage System for Gastric Cancer NCT03380052 | Seoul National University Bundang Hospital | — |
| Completed | An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemo NCT00226811 | Pfizer | Phase 2 |
| Completed | Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction NCT00374985 | Johannes Gutenberg University Mainz | Phase 1 / Phase 2 |
| Completed | Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding NCT00539877 | Samsung Medical Center | Phase 1 |
| Completed | A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma NCT00980382 | National Cancer Center, Korea | Phase 1 / Phase 2 |
| Completed | Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemothe NCT00087503 | Pfizer | Phase 2 |
| Unknown | Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway NCT00498134 | Hospital Authority, Hong Kong | N/A |
| Completed | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer NCT00054873 | Chiron Corporation | Phase 2 |
| Completed | Oxaliplatin in Gastric Cancer NCT00263354 | Sanofi | Phase 2 |
| Completed | A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non NCT00611507 | Sanofi | Phase 2 |
| Completed | Study of Adjuvant Radiochemotherapy for Gastric Cancer NCT00188266 | University Health Network, Toronto | Phase 1 / Phase 2 |
| Recruiting | Institut Paoli Calmettes Cardia Cancer Database NCT02869477 | Institut Paoli-Calmettes | — |
| Completed | Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancer NCT00036400 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |
| Completed | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver NCT00041808 | FeRx | Phase 1 / Phase 2 |
| Completed | Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample NCT00568438 | Stanford University | — |
| Completed | Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer NCT00042510 | Cancer Advances Inc. | Phase 2 |
| Completed | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotox NCT00001805 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Ga NCT00001332 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Trea NCT00270543 | Far Eastern Memorial Hospital | Phase 2 |